Cargando…

Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells

Aplastic anemia is rare disorder presenting with bone marrow failure syndrome due to autoimmune destruction of early hematopoietic stem cells (HSCs) and stem cell progenitors. Recent advances in newer genomic sequencing and other molecular techniques have contributed to a better understanding of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brzeźniakiewicz-Janus, Katarzyna, Rupa-Matysek, Joanna, Gil, Lidia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253510/ https://www.ncbi.nlm.nih.gov/pubmed/32270433 http://dx.doi.org/10.1007/s12015-020-09971-y

Ejemplares similares

Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice
por: Rupa‐Matysek, Joanna, et al.
Publicado: (2018)

Red Blood Cells Mean Corpuscular Volume (MCV) and Red Blood Distribution Width (RDW) Parameters as Potential Indicators of Regenerative Potential in Older Patients and Predictors of Acute Mortality – Preliminary Report
por: Brzeźniakiewicz-Janus, Katarzyna, et al.
Publicado: (2020)

Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia
por: Im, Ho Joon, et al.
Publicado: (2015)

Selected Hematological Biomarkers to Predict Acute Mortality in Emergency Department Patients. Recent Polish Hospital Statistics
por: Brzeźniakiewicz-Janus, Katarzyna, et al.
Publicado: (2020)

Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia
por: Smith, Julianne N. P., et al.
Publicado: (2016)

Clinical Profiles of Selected Biomarkers Identifying Infection and Cancer Patients: A Gorzów Hospital Example
por: Brzeźniakiewicz-Janus, Katarzyna, et al.
Publicado: (2019)

Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adults
por: Lee, Ji Hyun, et al.
Publicado: (2010)

Comorbidities, repeated hospitalizations, and age ≥ 80 years as indicators of anemia development in the older population
por: Michalak, Sylwia Sulimiera, et al.
Publicado: (2018)

Is Migraine an MPV-Related Disease? An Observational Study of Polish Neurological Patients
por: Brzeźniakiewicz-Janus, Katarzyna, et al.
Publicado: (2019)

Unexplained anemia in the elderly – a real life analysis of 981 patients
por: Michalak, Sylwia S., et al.
Publicado: (2019)

Late Epstein-Barr virus-related post-transplant lymphoproliferative disorder with intestinal involvement in patient with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: HJELLBAKK, HEDDA KLOSTER, et al.
Publicado: (2020)

Hematopoietic stem cell transplantation for severe aplastic anemia—experience of an institute in Taiwan
por: Bai, L. Y., et al.
Publicado: (2003)

First-Line Matched Related Donor Hematopoietic Stem Cell Transplantation Compared to Immunosuppressive Therapy in Acquired Severe Aplastic Anemia
por: Peinemann, Frank, et al.
Publicado: (2011)

Comparison of porcine ALG and rabbit ATG on outcomes of HLA-haploidentical hematopoietic stem cell transplantation for patients with acquired aplastic anemia
por: Chen, Juan, et al.
Publicado: (2022)

The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia
por: Lin, Fan, et al.
Publicado: (2022)

Gut inflammation in the pathogenesis of acquired aplastic anemia
por: Zhao, Xi-Chen, et al.
Publicado: (2020)

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
por: Yıldırmak, Yıldız, et al.
Publicado: (2012)

Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia
por: Guan, Yihong, et al.
Publicado: (2022)

Immune Reconstitution in Pediatric Aplastic Anemia after Allogeneic Hematopoietic Stem-cell Transplantation
por: Wang, Jiayu, et al.
Publicado: (2022)

Human Acquired Aplastic Anemia Patients' Bone-Marrow-Derived Mesenchymal Stem Cells Are Not Influenced by Hematopoietic Compartment and Maintain Stemness and Immune Properties
por: Sharma, Vandana, et al.
Publicado: (2021)

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia
por: Eapen, Mary, et al.
Publicado: (2020)

Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E, et al.
Publicado: (2017)

Hematopoietic Stem-Cell Transplantation versus Immunosuppressive Therapy in Patients with Adult Acquired Severe Aplastic Anemia: A Cost-Effectiveness Analysis
por: Zhang, Meng-Xue, et al.
Publicado: (2021)

Hematopoietic stem progenitor cells with malignancy‐related gene mutations in patients with acquired aplastic anemia are characterized by the increased expression of CXCR4
por: Katagiri, Takamasa, et al.
Publicado: (2022)

Hematopoietic stem cell loss and hematopoietic failure in severe aplastic anemia is driven by macrophages and aberrant podoplanin expression
por: McCabe, Amanda, et al.
Publicado: (2018)

Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia
por: Huo, Jiali, et al.
Publicado: (2020)

Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia
por: Gonzaga, Vivian Fonseca, et al.
Publicado: (2017)

Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility
por: Wang, Xing-An, et al.
Publicado: (2023)

P1310: HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEPATITIS‑ASSOCIATED APLASTIC ANEMIA AND NON‑HEPATITIS‑ASSOCIATED APLASTIC ANEMIA: A PROPENSITY SCORE-MATCHED ANALYSIS
por: LI, Jia
Publicado: (2023)

THPO gene variants in patients with acquired aplastic anemia
por: Padilha, Pedro Henrique, et al.
Publicado: (2018)

Total lymphoid irradiation based conditioning for hematopoietic stem cell transplantation in severe aplastic anemia
por: Lee, Yun-Hee, et al.
Publicado: (2012)

Autoimmune hemolytic anemia: current knowledge and perspectives
por: Michalak, Sylwia Sulimiera, et al.
Publicado: (2020)

Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E., et al.
Publicado: (2018)

Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia
por: Zhang, Yuanfeng, et al.
Publicado: (2022)

P823: THE INCIDENCE, OUTCOMES, AND RISK FACTORS OF SECONDARY POOR GRAFT FUNCTION IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACQUIRED APLASTIC ANEMIA
por: lin, F., et al.
Publicado: (2022)

Modern Medical Miracle: Matched Unrelated Donor Hematopoietic Stem Cell Transplant After Aplastic Anemia
por: Van Antwerp, Emily, et al.
Publicado: (2021)

Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single Centre Experience in Malaysia
por: Wilfred, Gilbert, et al.
Publicado: (2022)

Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
por: Medinger, Michael, et al.
Publicado: (2018)

Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
por: Zhao, Yufei, et al.
Publicado: (2023)

Recent advances and current challenges in allogeneic stem cell transplantation in patients with acquired severe aplastic anemia
por: Lee, Sung-Eun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r0ag55ihoq9fj3m250l16i721q